translation agency

Business Wire
AHF's FDA AIDS Protest Targets Approval of Gilead's Prevention Pill

January 22, 2012
Business Wire - January 22, 2012

WASHINGTON - Advocates from AIDS Healthcare Foundation (AHF) will host a protest at the headquarters of the Food and Drug Administration (FDA) Monday, January 23rd at 10:00am Eastern Time over the FDA's refusal to release documents regarding its contact and correspondence with Gilead Sciences about the potential FDA approval of Gilead's blockbuster AIDS drug Truvada for use as a form of HIV prevention in uninfected individuals. The FDA is now hastily considering approval of this drug despite numerous failed clinical trials, a move which many AIDS care providers and advocates believe is unwarranted based on the studies and would set a dangerous precedent.